| Original language | English (US) |
|---|---|
| Journal | Mediastinum |
| Volume | 6 |
| DOIs | |
| State | Published - 2022 |
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Endocrinology, Diabetes and Metabolism
- Oncology
- Radiology Nuclear Medicine and imaging
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Mediastinum, Vol. 6, 2022.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - ITMIG 2021 Tumor Board
T2 - a case of a 37-year-old man with TNM stage IVA thymoma
AU - Zielinski, Marcin
AU - Roden, Anja C.
AU - Truong, Mylene T.
AU - Van Raemdonck, Dirk
AU - Komaki, Ritsuko
AU - Wakelee, Heather
AU - Szolkowska, Malgorzata
N1 - Funding Information: ICMJE uniform disclosure form (available at https:// med.amegroups.com/article/view/10.21037/med-22-3/ coif). “The Series Dedicated to the 11th International Thymic Malignancy Interest Group Annual Meeting (Virtual ITMIG 2021)” was commissioned by the editorial office without any funding or sponsorship. MZ serves as an unpaid Associate Editor-in-Chief of Mediastinum from February 2020 to January 2024. ACR serves as an unpaid Associate Editor of Mediastinum from July 2021 to June 2023. MS served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Mediastinum from June 2021 to May 2023. ACR received Transplant Scholarly Time award “Unique Gene Expression Signatures in Lung Explants of Patients with Shortened Telomeres and their Prognostic Significance”, funded by Mayo Clinic Transplant Center, 2021-2023 and reported grant “Differential expression of inflammatory genes aids in the diagnosis of antibody mediated and acute rejection and their distinction from morphologic mimics in lung allografts” funded by DLMP Research Fund, 2019-2021, royalty for Contribution of medical educational material to up-to-date and honorarium from the College of American Pathologists for lecture. HW reports grants or contracts from ACEA Biosciences, Arrys Therapeutics, AstraZeneca/ Medimmune BMS, Clovis Oncology Genentech/Roche, Merck, Novartis, SeaGen, Xcovery, Helsinn, participation on Advisory Boards of AstraZeneca, Xcovery, Janssen, Daiichi Sankyo, Blueprint, Mirati, Helsinn, Merck, Takeda, Genentech/Roche, Cellworks and she is a president of the International Association for the Study of Lung Cancer (IASLC) and a member of Executive committee of ECOG-ACRIN. MS reports paid lectures for Boehringer Ingelheim, AstraZeneca Pharma Poland, Roche Polska, MSD Polska and she is a Secretary of the International Thymic Malignancy Interest Group, Chair of Thymic and Mediastinal Working Group in European Society of Pathology, Member of Main Revisory Board in the Polish Society of Pathology. The authors have no other conflicts of interest to declare.
PY - 2022
Y1 - 2022
UR - http://www.scopus.com/inward/record.url?scp=85136850279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136850279&partnerID=8YFLogxK
U2 - 10.21037/med-22-3
DO - 10.21037/med-22-3
M3 - Letter
AN - SCOPUS:85136850279
SN - 2522-6711
VL - 6
JO - Mediastinum
JF - Mediastinum
ER -